New strategy aims to stop liver cancer from coming back
Disease control
Not yet recruiting
This study is testing if giving an immunotherapy drug called atezolizumab before surgery to remove liver cancer can help prevent the cancer from returning. Researchers want to see if boosting the patient's immune system before the operation is more effective than surgery alone. T…
Phase: PHASE3 • Sponsor: University of Geneva, Switzerland • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC